The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma

Paul A. Spagnuolo, Jiayi Hu, Rose Hurren, +12

Blood

Searching for prognostic biomarkers for small renal masses in the urinary proteome

Ashley Di Meo, Ihor Batruch, Marshall Brown, +5

International Journal of Cancer

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma

Silvia Crescioli, Isabel Corrêa, Joseph Ng, +39

Nature Communications

An integrated proteomic and peptidomic assessment of the normal human urinome

Ashley Di Meo, Ihor Batruch, Arsani G. Yousef, +3

Clinical Chemistry and Laboratory Medicine (CCLM)

Prognostic urinary miRNAs for the assessment of small renal masses

Ashley Di Meo, Marshall Brown, Antonio Finelli, +3

Clinical Biochemistry

UrologyRenal PathologySmall Renal MassesPathologyMicrorna Detection +4

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2

Giulia Pellizzari, Olivier Martínez, Silvia Crescioli, +22

Journal for ImmunoTherapy of Cancer

Evaluation of Three Anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response

Ashley Di Meo, Jessica Miller, Anselmo Fabros, +9

The Journal of Applied Laboratory Medicine

A miRNA-based classification of renal cell carcinoma subtypes by PCR and<i>in situ</i>hybridization

Ashley Di Meo, Rola Saleeb, Samantha J. Wala, +12

Oncotarget

Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma

Nicole M. White-Al Habeeb, Ashley Di Meo, Andreas Scorilas, +7

Clinical & Experimental Metastasis

Potential Prognostic MarkerUrologyGenitourinary CancerKidney ResearchMedicine +6

What Is Wrong with Clinical Proteomics?

Ashley Di Meo, Eleftherios P. Diamandis, Henry Rodriguez, +3

Clinical Chemistry

Complex MixturesProtein AnalysisPathologyBiological Mass SpectrometryProteomic Technology +16